The aim of this study is to find out how patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis receiving NSAID-therapy are treated and managed by their doctor in usual clinical practice, how patients comply with their treatment and how satisfied they are with their treatment.
Study Type
OBSERVATIONAL
Enrollment
1,149
The incidence of selected GI events, classified as "symptomatic" or "complicated" GI events. Reported by the patients at the follow-up visits.
Time frame: Time from NSAID treatment prescription to first diagnosis of the GI event for each patient will be registered. Each patient will be followed up for 6 months.
Number of health care visits and days of hospitalisation (health care consumption) related to arthritic disorder and/or GI events as reported by the patients at the follow-up visits.
Time frame: Health care consumption accumulated over the 6 months study period will be registered.
Quality of life assessed by EuroQol-5 Dimension (EQ-5D) at baseline and the follow-up visits. Measure how selected GI events impact the EQ-5D score.
Time frame: Measurements at baseline, 3 months and 6 months
Adherence with NSAIDs and proton pump inhibitors (PPI) measured by Morisky-Green-Levine Medication Assessment Scale (MMAS) at baseline and follow-up visits.
Time frame: Measurements at baseline, 3 months and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Alsemberg, Belgium
Research Site
Anthée, Belgium
Research Site
Baisy-Thy, Belgium
Research Site
Blankenberge, Belgium
Research Site
Bois-de-Villers, Belgium
Research Site
Brussels, Belgium
Research Site
Champion, Belgium
Research Site
Chênée, Belgium
Research Site
Dour, Belgium
Research Site
Ecaussinnes, Belgium
...and 234 more locations